Established in 1976, J.B.Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s fastest growing pharmaceutical companies. An integrated, research-oriented, public listed organisation with a focus on supplying affordable, quality products both in India and International markets, JBCPL is trusted by healthcare professionals globally.

JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules. In India and International markets, JBCPL is also known as Unique Pharmaceutical Laboratories and is a division of JBCPL.

JBCPL exports too many countries worldwide with presence in US, Europe, Australia, South Africa, other developing countries, Russia and CIS. The Company continues to invest in growing its share in the regulated markets such as USA, Europe and Australia. JBCPL has a strong R&D and regulatory set-up for development of new drug delivery system and formulations, filing of ANDAs and DMFs. Its state-of-the-art manufacturing facilities are approved by health authorities of key regulated markets.

Business area of the company

J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs.

JB Chemicals & Pharmaceuticals Ltd.

Ajanta Pharma Ltd.

Piramal Enterprises Ltd.

Ipca Laboratories Ltd.

Glenmark Pharmaceuticals Ltd.

Laurus Labs Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Gland Pharma Ltd.

Pfizer Ltd.

Sanofi India Ltd.

Natco Pharma Ltd.

Alembic Pharmaceuticals Ltd.

Suven Pharmaceuticals Ltd.

Biocon Ltd.

Eris Lifesciences Ltd.

Market Cap	22,990 Cr	ROE	18.5%
P/E Ratio(TTM)	51.4	EPS(TTM)	0.0
P/B Ratio	9.2	Dividend Yield	0.3%
Industry P/E	41.7	Book Value	161.4
		Face Value	1.0

Fundamentals